Today $ARCAD (-0,34%) presented their mixed year results. Here is a small recap.
Arcadis – Full Year 2025 Results (19 February 2026)
Arcadis today reported its full year 2025 results, showing a mixed performance with stable financial strength, disciplined capital returns, and continued progress toward strategic targets.
Key Financial Figures:
• Net revenues: €3,760 million, representing a -0.5 % organic decline compared to 2024.
• Operating EBITA margin: 11.1 % (2024: 11.5 %).
• Earnings per share (EPS): €2.33 (2024: €2.70).
• Free cash flow (total): €288 million (2024: €228 million).
• Backlog (order book): €3,615 million, with +2.7 % organic growth year-on-year.
Dividends & Capital Returns:
• Dividend proposal: €1.05 per share (up from €1.00 in 2024).
• Arcadis returned €225 million to shareholders in 2025, through dividends (€89 million) and share buybacks (€136 million).
• The €175 million share buyback programme was completed in January 2026, resulting in a 5 % reduction in floating shares.
Operational Highlights:
• Q4 net revenues: €887 million, representing a -2.9 % organic decline in the fourth quarter.
• Fourth quarter operating EBITA margin: 10.8 % (Q4 2024: 12.6 %).
Additional Notes:
• Net debt to Operating EBITDA: 1.5x, within the company’s target range (1.5–2.5x).
• Arcadis also reduced headcount by approximately 1,100 employees as part of restructuring and cost discipline efforts.
• The company expects flat organic net revenue growth for 2026 with an improved operating EBITA margin of 11.7–12.0 %.
• A Capital Markets Day is planned for November 2026 to outline longer-term strategy.